IASLC
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...
Visita il sito del podcast e sostieni chi lo crea: www.iaslc.org
Dove ascoltare?
I podcast nell'app Replaio Radio In arrivoI podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast
Episodi
ESMO 2026 Highlights – Part 2 17.11.2026 59:27
In Part 2 of our ESMO 2026 Highlights series, Dr. Stephen Liu and Dr. Narjust Florez welcome Dr. Xiao-Rong Dong, Dr. Yi-Long Wu, and Dr. Chantal Decroisette to discuss three important clinical trials: SAFFRON, SANOVO, and PERSEE. The conversations explore emerging strategies for targeting MET in EGFR-mutated non-small cell lung cancer, advances in first-line immunotherapy, and the potential implic...
LCC in Japanese: Respiratory Comorbidities in Lung Cancer 13.11.2026 28:42
In this Japanese-language episode of Lung Cancer Considered, Dr. Misako Nagasaka speaks with Dr. Motoko Tachihara about managing lung cancer in patients with respiratory comorbidities, including interstitial lung disease (ILD), COPD, and pulmonary infections. They discuss key considerations for treatment selection, the use of emerging therapies in patients with pre-existing lung disease, and the i...
What’s on Your Plate Matters: Nutrition & Lung Cancer 10.11.2026 50:03
In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Urvi Shah and Dr. Krystle Zuniga to explore the critical role of nutrition in lung cancer care. The discussion highlights current evidence on nutrition and cancer outcomes, practical strategies to support patients during treatment and survivorship, and common misconceptions fueled by misinformation. Together, they...
LCC: ESMO Highlights in Spanish 06.11.2026 39:03
LCC in Spanish: ESMO 2026 Highlights En este episodio en español de Lung Cancer Considered, la Dra. Narjust Florez conversa con la Dra. Ana Velázquez Mañana sobre los principales avances en la investigación del cáncer de pulmón presentados en ESMO 2026 en Madrid. Destacan los resultados de los estudios DeLLphi-305, SAFFRON y Krascendo 1, explorando los avances en el tratamiento del cáncer de pulmó...
ESMO 2026 Highlights – Part 1 04.11.2026 1:26:37
In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategie...
LCC in Georgian: Virtual Tumor Board Advanced EGFR-positive Lung Cancer 30.10.2026 25:15
In this Georgian-language episode of Lung Cancer Considered, Dr. Elene Mariamidze is joined by Dr. Mariam Tchiabrishvili and Dr. Lasha Khmaladze for a multidisciplinary discussion of a challenging case of EGFR-mutated non-small cell lung cancer (NSCLC). Through a case-based discussion, they explore molecular testing, treatment strategies, management of brain metastases, and the role of EGFR tyrosi...
LCC in Arabic: WCLC 2026 Highlights 23.10.2026 41:45
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Nagla Karim moderates a discussion in Arabic about highlights from the conference with Dr. Bashir Abu Aqeel, Dr....
LCC in Mandarin: WCLC 2026 Highlights with Experts from Taiwan 20.10.2026 1:01:26
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao, Dr. Mong-Wei Lin, and Dr. Po-Lan Su...
LCC in Hebrew: WCLC 2026 Highlights 16.10.2026 38:29
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Ory Wiesel moderates a discussion in Hebrew with Dr. Jair Bar, Dr. Nir Peled, and Dr. Hadas Sorotsky about highl...
WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth 13.10.2026 18:40
Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr. Sara Fra, Dr. Cassio Murilo Hidalgo Filho, and Dr. Nan Sethakorn discuss the research presented at the meeting, the value of bringing together a multidisciplinary and international c...
LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026 09.10.2026 37:55
The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul. In this episode, Dr. Nagla Karim discusses highlights from the workshop in A...
LCC in Korean WCLC 2026 Highlights 06.10.2026 45:30
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the confe...
WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care 05.10.2026 24:36
In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting. They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communica...
WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care 01.10.2026 34:01
Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions. Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is ad...
WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic 29.09.2026 44:28
Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic. Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention,...
LCC in Czech: WCLC 2026 Highlights 24.09.2026 10:59
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Marie Drösslerová moderates a discussion in Czech about breakthrough advances in thoracic oncology presented at...
LCC in Spanish: WCLC 2026 Highlights 17.09.2026 48:55
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at t...
LCC in Portuguese: WCLC 2026 Highlights 17.09.2026 29:00
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented...
Live From WCLC 2026: Tuesday Highlights & Meeting Summary 15.09.2026 44:37
In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer. Guests Dr. Julia Rotow, Dr. Roy Herbst, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings co...
LCC in Mandarin: WCLC 2026 Highlights 15.09.2026 37:12
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about breakthrough advances in thoracic oncology presented...
Live From WCLC 2026: Monday Highlights 14.09.2026 31:18
In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference and ask what changes in clinic on Monday. A ROS1 drug that protects the brain and a first line combination that could not beat a decade old standard. Dr. Alexander Drilon brings the first line ARROS-1 data on zidesamtinib, and Dr. Giannis Mountzios...
Live From WCLC 2026: Sunday Highlights 14.09.2026 47:07
From the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, Dr. Narjust Florez talks with Dr. Chad Rusthoven about MAVERICK, the trial that tested MRI surveillance alone against prophylactic cranial irradiation in small cell lung cancer, and with Dr. Chul Kim about the final overall survival results of PAPILLON, amivantamab plus chemotherapy in EGFR exon 20 insertion NSCLC. Both guests sh...
Before You Go: A Practical Guide to WCLC 2026 in Seoul 04.09.2026 38:27
Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez. From preparing for the flight and beating jet lag to navigating COEX, networking, exploring Seoul’s food scene, and making the most of the meeting, they share practical tips to help attendees arrive prepared and enjoy the full WCLC experience.
Beyond Stage IV: Rethinking Oligometastatic Lung Cancer 01.09.2026 47:30
In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care. Gues...
LCC in Korean: The Role of Immunotherapy in Lung Cancer 28.08.2026 46:42
In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer treatment continuum. They explore perioperative strategies for resectable NSCLC, treatment selection and biomarkers in advanced disease, emerging research, and what they are looking forward to at WCLC 202...
Podcast simili
Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici